Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19Monique G.P. van der Wijst, Chun Ye, Anton Ogorodnikov et al.|Science Translational Medicine|2021Cited by 237
BLOOD COMPONENTS: Screening of single‐donor apheresis platelets for bacterial contamination: the PASSPORT study resultsLarry J. Dumont, Peyton Metzel, Steven Kleinman et al.|Transfusion|2009Cited by 131
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry studyJonathon W. Senefeld, Janis E. Blair, Patrick W. Johnson et al.|PLoS Medicine|2021Cited by 65
In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST CollaborativeLarry J. Dumont, Scott Murphy, James P. AuBuchon et al.|Transfusion|2006Cited by 62
High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020Shuting Zhang, Deborah T. Hung, Peijun Ma et al.|mBio|2023Cited by 18